Next Post

European Commission grants marketing authorisation to Valneva's COVID-19 shot

The logo of French-Austrian biotech agency Valneva is viewed exterior their headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner Sign up now for Totally free unrestricted access to Reuters.com Sign up June 24 (Reuters) – French drugmaker Valneva’s (VLS.PA) COVID-19 vaccine has acquired internet marketing authorisation from the European […]